Abstract
Diocleinae lectins administered per oral route in mice inhibited the abdominal constrictions induced by acetic acid. The percentage of the lectins antinociception varied from 61% for Canavalia grandiflora (ConGf) to 20% for Dioclea violacea. ConGf inhibited contortions at all doses tested but not in a dose-dependent manner, involving carbohydrate recognition.
Keywords: Lectins, Diocleinae subtribe, antinociception, Canavalia grandiflora, carbohydrate recognition
Protein & Peptide Letters
Title: Antinociceptive Activity of Lectins from Diocleinae Seeds on Acetic Acid-Induced Writhing Test in Mice
Volume: 16 Issue: 9
Author(s): Fernanda R. Holanda, Andrelina N. Coelho-de-Sousa, Ana M.S. Assreuy, Jose Henrique Leal-Cardoso, Alana F. Pires, Kyria S. do Nascimento, Cicero S. Teixeira, Benildo S. Cavada and Claudia F. Santos
Affiliation:
Keywords: Lectins, Diocleinae subtribe, antinociception, Canavalia grandiflora, carbohydrate recognition
Abstract: Diocleinae lectins administered per oral route in mice inhibited the abdominal constrictions induced by acetic acid. The percentage of the lectins antinociception varied from 61% for Canavalia grandiflora (ConGf) to 20% for Dioclea violacea. ConGf inhibited contortions at all doses tested but not in a dose-dependent manner, involving carbohydrate recognition.
Export Options
About this article
Cite this article as:
Holanda R. Fernanda, Coelho-de-Sousa N. Andrelina, Assreuy M.S. Ana, Leal-Cardoso Henrique Jose, Pires F. Alana, do Nascimento S. Kyria, Teixeira S. Cicero, Cavada S. Benildo and Santos F. Claudia, Antinociceptive Activity of Lectins from Diocleinae Seeds on Acetic Acid-Induced Writhing Test in Mice, Protein & Peptide Letters 2009; 16 (9) . https://dx.doi.org/10.2174/092986609789055304
DOI https://dx.doi.org/10.2174/092986609789055304 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Controversial Role of Adenosine A2A Receptor Antagonists as Neuro-protective Agents
Current Medicinal Chemistry - Central Nervous System Agents Design and Synthesis of 2-(Arylmethylideneamino) Isoindolines as New Potential Analgesic and Anti-Inflammatory Agents: A Molecular Hybridization Approach
Current Pharmaceutical Design Biology of Protooncogene c-kit Receptor and Spermatogenesis
Current Pharmacogenomics Autophagy in Diabetic Retinopathy
Current Neuropharmacology Role of FXR in Regulating Bile Acid Homeostasis and Relevance for Human Diseases
Current Drug Targets - Immune, Endocrine & Metabolic Disorders IL-6 and Crohns Disease
Current Drug Targets - Inflammation & Allergy Monitoring Calcific Aortic Valve Disease: The Role of Biomarkers
Current Medicinal Chemistry Discovery of Novel Genes Mediating Glucose and Lipid Metabolisms
Current Protein & Peptide Science Microglial Senescence
CNS & Neurological Disorders - Drug Targets Prediction of Biological Activity Spectra for Substances: Evaluation on the Diverse Sets of Drug-Like Structures
Current Medicinal Chemistry Inhibition of the Function of TRPV1-Expressing Nociceptive Sensory Neurons by Somatostatin 4 Receptor Agonism: echanism and Therapeutical Implications
Current Topics in Medicinal Chemistry Multiple Drug Targets in the Management of Type 2 Diabetes
Current Drug Targets Development of FXR, PXR and CAR Agonists and Antagonists for Treatment of Liver Disorders
Current Topics in Medicinal Chemistry Vitamin D : Autoimmunity and Gender
Current Medicinal Chemistry Substance Abuse, HIV-1 and Hepatitis
Current HIV Research Microfluidic Methods for Non-Viral Gene Delivery
Current Gene Therapy Urokinase Receptor (uPAR) Ligand based Recombinant Toxins for Human Cancer Therapy
Current Pharmaceutical Design Endogenous Angiogenesis Inhibitors as Therapeutic Agents: Historical Perspective and Future Direction
Recent Patents on Anti-Cancer Drug Discovery DNA Vaccination in Oncology: Current Status, Opportunities and Perspectives
Current Clinical Pharmacology Catastrophic Antiphospholipid Syndrome - 20 Years Later
Current Rheumatology Reviews